Shift Bioscience

Last updated: October 09, 2024

Daniel Ives, CEO and Founder
Daniel Ives, CEO and Founder
UK | Add Funding

Website: http://shiftbioscience.com

Shift Bioscience is creating new drug targets and diagnostic tools to enhance healthy lifespan through the repair of mitochondrial genes that cause neurodegenerative diseases or coronary heart disease.